Long-term clinical outcomes and recurrence factors in intracranial germinoma - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Prolonged Clinical Results and Recurrence Determinants in Intracranial Germinoma

  • By

  • Masashi Higashino

  • Kazuhiro Tanaka

  • Takeaki Ishihara

  • Hiroaki Nagashima

  • Yuichi Fujita

  • Yosuke Fujimoto

  • Masaaki Kohta

  • Yoichi Uozumi

  • Hidehito Kimura

  • Ryohei Sasaki

  • Takashi Sasayama

  • June 4, 2026

Share

  • 1

    Intracranial germinoma is a rare CNS tumor with a higher incidence in East Asia, particularly Japan, compared to Western countries.

  • 2

    Germinomas have excellent long-term survival rates, with 30-year overall survival rates ranging from 61.9% to 100% based on treatment.

  • 3

    Recurrence remains a significant concern, with 5- and 10-year progression-free survival rates between 74% and 91%.

  • 4

    Whole ventricular irradiation is the current standard treatment, as focal radiation increases the risk of distant relapses.

  • 5

    This study analyzed long-term outcomes and recurrence patterns in 56 patients treated at Kobe University over four decades.

Original Source(s)

Related Content